Matthew F. Mescher

Matthew F. Mescher's AcademicInfluence.com Rankings

Matthew F. Mescher

Biology

#13491

World Rank

#17037

Historical Rank

Immunology

#932

World Rank

#956

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Matthew F. Mescher Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Matthew F. Mescher's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. (1999) (677)
Signals required for programming effector and memory development by CD8+ T cells (2006) (638)
Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation1 (2005) (599)
Inflammatory cytokines as a third signal for T cell activation. (2010) (503)
Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells (2003) (429)
CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism. (1999) (332)
Purification and characterization of a prokaryotic glycoprotein from the cell envelope of Halobacterium salinarium. (1976) (259)
Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN1 (2009) (238)
The Roles of IL-12 in Providing a Third Signal for Clonal Expansion of Naive CD8 T Cells1 (2002) (221)
CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine 1 (2003) (195)
Cytotoxic T lymphocyte mediated lysis without release of serine esterase (1987) (191)
Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. (1999) (188)
CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. (1999) (181)
CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. (1998) (181)
Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo. (1999) (178)
Actin-containing matrix associated with the plasma membrane of murine tumour and lymphoid cells (1981) (172)
The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. (2013) (168)
ICAM‐1 and B7‐1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM‐1 (1999) (153)
Peptide Antigen Priming of Naive, But Not Memory, CD8 T Cells Requires a Third Signal That Can Be Provided by IL-121 (2002) (139)
IL-12 Enhances CD8 T Cell Homeostatic Expansion1 (2001) (136)
Activated CD8 binding to class I protein mediated by the T-cell receptor results in signalling (1990) (133)
IL-21 Promotes Differentiation of Naive CD8 T Cells to a Unique Effector Phenotype1 (2007) (133)
Alloreactive T cells discriminate among a diverse set of endogenous peptides. (1991) (132)
Gene Regulation and Chromatin Remodeling by IL-12 and Type I IFN in Programming for CD8 T Cell Effector Function and Memory1 (2009) (129)
The roles of CD8 in cytotoxic T lymphocyte function. (1993) (127)
Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation (2007) (126)
Structural (shape-maintaining) role of the cell surface glycoprotein of Halobacterium salinarium. (1976) (123)
Surface contact requirements for activation of cytotoxic T lymphocytes. (1992) (120)
Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response. (1998) (116)
Cutting Edge: Bcl-3 Up-Regulation by Signal 3 Cytokine (IL-12) Prolongs Survival of Antigen-Activated CD8 T Cells1 (2005) (116)
Activation-Induced Nonresponsiveness: A Th-Dependent Regulatory Checkpoint in the CTL Response1 (2002) (106)
Signaling pathways activated by leukocyte function-associated Ag-1-dependent costimulation. (1999) (105)
Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis1 (2005) (102)
CD4 T Cell-Dependent Conditioning of Dendritic Cells to Produce IL-12 Results in CD8-Mediated Graft Rejection and Avoidance of Tolerance (2005) (97)
Cytotoxic T-lymphocyte activation involves a cascade of signalling and adhesion events (1992) (96)
Protein and Carbohydrate Composition of the Cell Envelope of Halobacterium salinarium (1974) (92)
B7‐1‐dependent co‐stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells (1997) (90)
Characterization of an anti-H-2 monoclonal antibody and its use in large-scale antigen purification. (1981) (85)
Opposing Effects of IL-2 in Tumor Immunotherapy: Promoting CD8 T Cell Growth and Inducing Apoptosis1 (2002) (74)
Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer (2011) (73)
Cutting Edge: IL-12 and Type I IFN Differentially Program CD8 T Cells for Programmed Death 1 Re-expression Levels and Tumor Control (2013) (73)
Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes. (1989) (72)
Signal 3 Availability Limits the CD8 T Cell Response to a Solid Tumor1 (2007) (72)
Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses1 (2008) (71)
Purification of the H-2Kk molecule of the murine major histocompatibility complex. (1979) (69)
Autocrine IFN-γ Promotes Naive CD8 T Cell Differentiation and Synergizes with IFN-α To Stimulate Strong Function (2012) (67)
The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins (1978) (67)
Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles. (1978) (65)
The Adjuvant Effects of Mycobacterium tuberculosis Heat Shock Protein 70 Result from the Rapid and Prolonged Activation of Antigen-Specific CD8+ T Cells In Vivo1 (2002) (62)
Migration and activation of antigen-specific CD8+ T cells upon in vivo stimulation with allogeneic tumor. (1997) (61)
Artificial cell surface constructs for studying receptor-ligand contributions to lymphocyte activation. (1997) (58)
Molecular Interactions in the Activation of Effector and Precursor Cytotoxic T Lymphocytes (1995) (57)
Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing. (1981) (56)
Cytotoxic T cell activation by class I protein on cell-size artificial membranes: antigen density and Lyt-2/3 function. (1987) (53)
Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen. (1980) (53)
ICAM-1–Dependent Homotypic Aggregates Regulate CD8 T Cell Effector Function and Differentiation during T Cell Activation (2013) (53)
Activation of CD8-dependent cytotoxic T lymphocyte adhesion and degranulation by peptide class I antigen complexes. (1993) (52)
In Vivo Augmentation of Tumor-Specific CTL Responses by Class I/Peptide Antigen Complexes on Microspheres (Large Multivalent Immunogen)1 (2003) (52)
Signaling Alterations in Activation-Induced Nonresponsive CD8 T Cells1 (2001) (51)
Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation. (2007) (51)
Short term exposure to cis unsaturated free fatty acids inhibits degranulation of cytotoxic T lymphocytes. (1990) (50)
Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors. (2007) (50)
Contribution of lymphocyte function-associated-1/intercellular adhesion molecule-1 binding to the adhesion/signaling cascade of cytotoxic T lymphocyte activation (1994) (50)
Secondary cytolytic T lymphocyte stimulation by purified H-2Kk in liposomes. (1981) (49)
Cellular interactions in the generation of cytolytic T lymphocyte responses Analysis of the helper T cell pathway (1981) (49)
Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins. (2001) (48)
Activation of polyphosphoinositide hydrolysis in T cells by H-2 alloantigen but not MLS determinants. (1990) (48)
Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes. (2004) (44)
The thymus leukemia antigen binds human and mouse CD8 (1991) (44)
The Poststimulation Program of CD4 Versus CD8 T Cells (Death Versus Activation-Induced Nonresponsiveness)1 (2002) (43)
Cytoskeletal function in CD8- and T cell receptor-mediated interaction of cytotoxic T lymphocytes with class I protein (1991) (41)
Glycosylation of the surface glycoprotein of Halobacterium salinarium via a cyclic pathway of lipid‐linked intermediates (1978) (41)
LFA-1-Mediated Costimulation of CD8+ T Cell Proliferation Requires Phosphatidylinositol 3-Kinase Activity1 (2001) (40)
Cytolytic T-lymphocyte response to isolated class I H2 proteins and influenza peptides (1989) (39)
Formation of lipid-linked sugar compounds in Halobacterium salinarium. Presumed intermediates in glycoprotein synthesis. (1976) (39)
Solid-phase binding of class I and II MHC proteins: immunoassay and T cell recognition. (1989) (37)
Extensive polymorphism surrounding the murine Ia A beta chain gene. (1983) (36)
Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma (2004) (32)
Antigen Processing and MHC-II Presentation by Dermal and Tumor-Infiltrating Dendritic Cells1 (2009) (30)
Analysis of the two-signal requirement for precursor cytolytic T lymphocyte activation using H-2Kk in liposomes. (1982) (30)
Purification of murine MHC antigens by monoclonal antibody affinity chromatography. (1983) (29)
Autologous Large Multivalent Immunogen Vaccine in Patients With Metastatic Melanoma and Renal Cell Carcinoma (2008) (29)
Triton X-100 extraction of P815 tumor cells: evidence for a plasma membrane skeleton structure (1985) (28)
Cell-sized, supported artificial membranes (pseudocytes): response of precursor cytotoxic T lymphocytes to class I MHC proteins. (1986) (27)
CD8 Memory T Cells (CD44, Ly-6C) Are More Sensitive than Naive Cells (CD44, Ly-6C) to TCR/CD8 Signaling in Response to Antigen (1998) (27)
Carbohydrate moieties of major histocompatibility complex class I alloantigens are not required for their recognition by T lymphocytes (1985) (26)
Exogenous β2‐microglobulin is required for antigenic peptide binding to isolated class I major histocompatibility complex molecules (1991) (26)
Glycoproteins as cell-surface structural components (1981) (26)
Antigen Controls IL-7Rα Expression Levels on CD8 T Cells during Full Activation or Tolerance Induction1 (2008) (25)
T cell receptor and CD8‐dependent tyrosine phosphorylation events in cytotoxic T lymphocytes: activation of p56lck by CD8 binding to class I protein (1996) (25)
The induction of secondary cytolytic T lymphocytes by solubilized membrane proteins (1978) (25)
Augmentation of in vivo cytotoxic T lymphocyte activity and reduction of tumor growth by large multivalent immunogen. (1992) (24)
Kinetics of cytolytic T lymphocyte binding to target cells in suspension. (1981) (24)
Bacitracin induces sphere formation in Halobacterium species which lack a wall peptidoglycan. (1975) (24)
Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes. (1985) (23)
T cell receptor-mediated signaling occurs in the absence of inositol phosphate production. (1988) (23)
Phosphatidylinositol 3 kinase activity is not essential for B7-1-mediated costimulation of proliferation or development of cytotoxicity in murine T cells. (1996) (22)
Specific reversal of cytolytic T cell-target cell functional binding is induced by free target cells. (1981) (22)
Large-scale purification of murine I-Ak and I-Ek antigens and characterization of the purified proteins. (1983) (22)
The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses. (2007) (22)
Immunotherapy of established murine tumors with large multivalent immunogen and cyclophosphamide. (1996) (21)
The requirements for antigen multivalency in class I antigen recognition and triggering of primed precursor cytolytic T lymphocytes. (1986) (20)
Agorins: major structural proteins of the plasma membrane skeleton of P815 tumor cells (1986) (20)
Signals for activation of CD8-dependent adhesion and costimulation in CTLs. (1994) (20)
Growth-inhibitory activity of lymphoid cell plasma membranes. I. Inhibition of lymphocyte and lymphoid tumor cell growth (1984) (20)
Inhibition of lymphoid cell growth by a lipid-like component of macrophage hybridoma cells. (1986) (19)
Cytotoxic T‐lymphocyte interaction with fibronectin and vitronectin: activated adhesion and cosignalling (1997) (17)
Antigen Processing and MHC-II Presentation by Dermal and Tumor-Infiltrating Dendritic Cells (2009) (17)
Growth-inhibitory activity of lymphoid cell plasma membranes. II. Partial characterization of the inhibitor (1984) (17)
Hairpin configuration of H-2Kk in liposomes formed by detergent dialysis. (1984) (16)
Class I alloantigen is sufficient for cytolytic T lymphocyte binding and transmembrane signaling (1988) (15)
Equilibrium binding of cytotoxic T lymphocytes to class I antigen. (1991) (15)
T cell recognition of nonpolymorphic determinants on H-2 class I molecules. (1988) (15)
Stimulation of tumor-specific immunity using tumor cell plasma membrane antigen. (1997) (14)
Lymphocyte recognition of H-2 antigen in liposomes. (1981) (13)
Role of I-region gene products in T cell activation. I. Stimulation of T lymphocyte proliferative responses by subcellular membrane preparations containing Ia alloantigens. (1982) (13)
Adoptive T Cell Therapy with IL-12–Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity (2020) (13)
Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade (2019) (11)
The plasma membrane 'skeleton' of tumor and lymphoid cells: a role in cell lysis? (1985) (11)
Inhibition of the induction of cytolytic T lymphocytes with alloantisera directed against H-2K and H-2D gene products. (1978) (11)
Antigen recognition by T cells. Quantitative effects of augmentation by antibodies providing accessory interactions. (1990) (11)
Cell-mediated immunity to viral glycoproteins. (1980) (11)
Cytolytic T lymphocyte recognition of subcellular antigen. (1982) (10)
IgE receptor-mediated arachidonic acid release by rat basophilic leukemia (RBL-2H3) cells: possible role in activating degranulation. (1992) (10)
Murine Cell Surface Immunoglobulin: Two Forms of δ-Heavy Chain (1979) (9)
Proteolytic modifications of the carboxyl-terminal region of H-2Kk. (1982) (8)
T-cell receptor-activated adhesion systems. (1990) (8)
Induction of allogeneic cytolytic T lymphocytes by partially purified membrane glycoproteins. (1980) (8)
Murine cell surface immunoglobulin: two native IgD structures. (1980) (7)
Genetic control of murine IgD structural heterogeneity. (1980) (7)
CD8 and antigen-specific T cell adhesion cascades. (1993) (7)
IL-12 Memory , CD 8 T Cells Requires a Third Peptide Antigen Priming of Naive , But Not (2002) (7)
The ability of Ia and H‐2Kk‐bearing membranes to replace the antigen‐presenting cell in an H‐2Kkallogeneic cytotoxic T cell response (1985) (7)
Stimulation of secondary anti-MSV cytolytic T lymphocytes with MBL-2 reconstituted membranes. (1983) (6)
Inhibition of normal lymphocyte responses by cell membranes. (1984) (6)
The Interaction of MHC Antigens with the Plasma Membrane and the Other Cellular Components (1982) (6)
Activated adhesion of CTL to MHC class I but not to fibronectin is inhibited by cis unsaturated fatty acids and phenylarsine oxide. (1995) (6)
Role of phosphoinositide 3‐kinase in TCR‐signaled regulation of CD8‐mediated adhesion to class I MHC protein (2001) (6)
Specific reversal of cytolytic T lymphocyte--target cell interaction. (1981) (5)
The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes. (1979) (4)
Murine cell surface immunoglobulin: two forms of delta-heavy chain. (1979) (4)
Cytolytic T lymphocyte mediated chromium-51 release versus spontaneous release from blast and spleen cell targets at low temperatures. (1981) (3)
The Thymus Leukemia Antigen Binds Human and Mouse CD 8 By (2003) (3)
Th-Dependent Regulatory Checkpoint in the Activation-Induced Nonresponsiveness: A (2002) (3)
Antitumor CD 8 T Cell Responses Dendritic Cells Limits CD 4 T Cell Help for Defective MHC Class II Presentation by (2008) (3)
Presence of Costimulation ( Anergic ) Following Activation in the T Cells Become Nonresponsive + CD 8 (1999) (2)
Adjuvants and the Initiation of T-Cell Responses (2006) (2)
INDUCTION OF VIRUS-SPECIFIC H-2 RESTRICTED MURINE CTL BY LIPOSOMES (1979) (2)
Phosphatidylinositol 3-Kinase Activity Cell Proliferation Requires T + LFA-1-Mediated Costimulation of CD 8 (2001) (1)
Cellular interactions in the regulation of the cytolytic T-lymphocyte response: the effect of suboptimal antigen dose. (1981) (1)
Plasma membrane matrix of murine tumor cells (1984) (1)
Maintaining protection against invasive bacteria with protein- polysaccharide conjugate vaccines (2009) (1)
CTL Recognition of Purified MHC Antigens and Other Cell Surface Ligands (1993) (1)
The shape-maintaining component of halobacterium salinarium: a cell surface glycoprotein. (1977) (1)
Avoidance of Tolerance CD8-Mediated Graft Rejection and Dendritic Cells to Produce IL-12 Results in CD4 T Cell-Dependent Conditioning of (2005) (0)
The use of purified H-2 antigens to define the helper T cell pathway involved in cytolytic T lymphocyte induction (1980) (0)
CellsSignal for Clonal Expansion of Naive CD8 T The Roles of IL-12 in Providing a Third (2002) (0)
Antigen processing and MHC-II presentation by dermal and tumor infiltrating Dendritic Cells (78.26) (2009) (0)
T Cells to a Unique Effector Phenotype IL-21 Promotes Differentiation of Naive CD8 (2007) (0)
Structural and functional analysis of T cell responses to Ia antigens (1984) (0)
T the More Rapid and Efficient Memory CD8 Memory T Cells Make a Major Contribution to Qualitative Differences Between Naive and (1998) (0)
Differentiation during T Cell Activation Regulate CD8 T Cell Effector Function and Dependent Homotypic Aggregates - ICAM-1 (2013) (0)
Carbohydrate moieties of H-2K(k) class I alloantigens are not required for their recognition by precursor CTL (1985) (0)
Surface Carbohydrates of the Prokaryotic Cell, I.W. Sutherland (Ed.). Academic Press, Chichester, New York, Brisbane and Toronto (1977), ISBN: 0 12 677850 7 (1978) (0)
CD8 T Cell Effector Function and Memory for by IL-12 and Type I IFN in Programming Gene Regulation and Chromatin Remodeling (2009) (0)
CostimulationFunction-Associated Ag-1-Dependent Signaling Pathways Activated by Leukocyte (1999) (0)
Abstract A65: Mechanisms of melanoma cell resistance to phagocytosis (2017) (0)
This information is current as To Stimulate Strong Function α Differentiation and Synergizes with IFN-Promotes Naive CD 8 T Cell γ Autocrine IFN - (2012) (0)
Purification and Characterization of a Prokaryotic Glycoprotein from the Cell Envelope of HaLobacterium saZinarium (2002) (0)
Nonresponsive CD 8 T Cells Signaling Alterations in Activation-Induced Ee (2001) (0)
Programming for a CD8 T Cell Memory Response Requires IL-12 and/or Type I IFN (95.23) (2007) (0)
Nonresponsive CD8 T Cells Signaling Alterations in Activation-Induced (2001) (0)
Valuable … interesting … stimulating (1978) (0)
T Cells + and CD 8 + Signal for Activation of Naive CD 4 Inflammatory Cytokines Provide a Third (1999) (0)
The Role of CD8-Class I Interactions in CTL Function (1993) (0)
Antigen-Activated CD8 T Cells 3 Cytokine (IL-12) Prolongs Survival of Cutting Edge: Bcl-3 Up-Regulation by Signal (2004) (0)
Dendritic cell tumor‐antigen processing and activation of tumor‐specific T cells (2008) (0)
Activation-Induced Nonresponsiveness ) CD 8 T Cells ( Death Versus The Poststimulation Program of CD 4 Versus (2002) (0)
In Vivo T Cells + Tolerizing to Immunizing for CD8 Peptide Antigen Administration from Adjuvant Effect of IL-12: Conversion of (1999) (0)
Cellsby Dermal and Tumor-Infiltrating Dendritic Antigen Processing and MHC-II Presentation (2009) (0)
Allogeneic cytolytic t lymphocyte stimulation by purified h-2kk in liposomes. Abstr. (1980) (0)
Antigen-Specific CD 8 from the Rapid and Prolonged Activation of Heat Shock Protein 70 Result tuberculosis Mycobacterium The Adjuvant Effects of (2002) (0)
Artificial antigen-presenting Cells: Large multivalent immunogens (2012) (0)
Autocrine IFN-gamma promotes limited differentiation of naïve CD8 T cells and synergizes with Type I IFN to stimulate optimal effector functions (110.5) (2012) (0)
(reconstituted membrane vesicles/plasma membrane matrix/matrix-containing liposomes) (2016) (0)
Extensive Restriction Site Polymorphism Surrounding a Single Copy I-Aβ Gene (1983) (0)
Abstract 4082: CD47 blockade to enhance adaptive anti-tumor immune responses (2014) (0)
Expansion and Differentiation Signal to CD8 T Cells to Stimulate Clonal Cutting Edge: Type I IFNs Provide a Third (2005) (0)
Abstract A143: Melanoma cell resistance to phagocytosis is unrelated to expression of conventional “eat-me/don't eat-me” signals (2016) (0)
Structural heterogeneity of murine IgD during ontogeny. (1982) (0)
MURINE IgD IS STRUCTURALLY HETEROGENEOUS WHEN IT FIRST APPEARS DURING ONTOGENY (1982) (0)
IL-12 and Type I IFN differentially program CD8 T cells for PD-1 expression levels and tumor control (127.32) (2012) (0)
Development Requires IL-12 or Type I IFN Programming for CD 8 T Cell Memory (2009) (0)
Costimulation, and Signal 3 Cytokine Prolonged Exposure to Antigen, Development of Effector Function Require CD8 T Cell Clonal Expansion and (2003) (0)
Abstract A051: Melanoma displays an evolutionarily conserved resistance to upregulation of prophagocytic signals and to CD47 blockade (2019) (0)
Session V: Strategies for immunization - Large Multivalent Immunogen (LMI) immunotherapy (2003) (0)
Immunotherapy: Promoting CD8 T Cell Opposing Effects of IL-2 in Tumor (2002) (0)
Multivalent Immunogen ) Complexes on Microspheres ( Large CTL Responses by Class I / Peptide Antigen In Vivo Augmentation of Tumor-Specific (2002) (0)
Cellsfor Clonal Expansion of Naive CD8 T The Roles of IL-12 in Providing a Third (2017) (0)
and Tumor Control Programmed Death 1 Re-expression Levels Differentially Program CD8 T Cells for Cutting Edge: IL-12 and Type I IFN (2013) (0)
Cytolysis toResponse to Antigen but Lack Granzyme B Signal 3 Tolerant CD 8 T Cells Degranulate in (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Matthew F. Mescher?

Matthew F. Mescher is affiliated with the following schools:

Matthew F. Mescher's Academic­Influence.com Rankings

Why Is Matthew F. Mescher Influential?

Matthew F. Mescher's Published Works

Published Works

What Schools Are Affiliated With Matthew F. Mescher?

Matthew F. Mescher's AcademicInfluence.com Rankings